Anna Pagonakis

Array ( [id] => 8173665 [patent_doc_number] => 20120108559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'RECEPTOR ACTIVATOR OF THE RANK RECEPTOR COMPLEX INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/144568 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3151 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108559.pdf [firstpage_image] =>[orig_patent_app_number] => 13144568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784686 [patent_doc_number] => 20120046242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY' [patent_app_type] => utility [patent_app_number] => 13/141838 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14147 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046242.pdf [firstpage_image] =>[orig_patent_app_number] => 13141838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657336 [patent_doc_number] => 20110306605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'COUMARIN-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE AND CANCER' [patent_app_type] => utility [patent_app_number] => 13/140791 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38291 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306605.pdf [firstpage_image] =>[orig_patent_app_number] => 13140791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427717 [patent_doc_number] => 08703792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation' [patent_app_type] => utility [patent_app_number] => 13/140209 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16082 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267518 [patent_doc_number] => 20100298377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'NOVEL SUBSTITUTED INDAZOLES, THE PREPARATION THEREOF AND USE OF SAME IN THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 12/636357 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34840 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298377.pdf [firstpage_image] =>[orig_patent_app_number] => 12636357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968912 [patent_doc_number] => 08507724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Compounds for use in the treatment of pain' [patent_app_type] => utility [patent_app_number] => 13/133569 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 14461 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212455 [patent_doc_number] => 20110135755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Combination therapies for treating neoplastic disease' [patent_app_type] => utility [patent_app_number] => 12/654047 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6970 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135755.pdf [firstpage_image] =>[orig_patent_app_number] => 12654047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353344 [patent_doc_number] => 20100086553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'ANTITUMOR AGENT' [patent_app_type] => utility [patent_app_number] => 12/632182 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5080 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086553.pdf [firstpage_image] =>[orig_patent_app_number] => 12632182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7581000 [patent_doc_number] => 20110294883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS INTENDED FOR USE AS A DRUG' [patent_app_type] => utility [patent_app_number] => 13/132231 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16399 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294883.pdf [firstpage_image] =>[orig_patent_app_number] => 13132231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555523 [patent_doc_number] => 08067424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Selective inhibitors for cyclin-dependent kinases' [patent_app_type] => utility [patent_app_number] => 12/631373 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 46565 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067424.pdf [firstpage_image] =>[orig_patent_app_number] => 12631373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6515952 [patent_doc_number] => 20100216810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'HETEROCYCLIC COMPOUND AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/628697 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57412 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216810.pdf [firstpage_image] =>[orig_patent_app_number] => 12628697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502047 [patent_doc_number] => 20110263713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'POLYMORPHS' [patent_app_type] => utility [patent_app_number] => 13/131229 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4641 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263713.pdf [firstpage_image] =>[orig_patent_app_number] => 13131229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696091 [patent_doc_number] => 20110230499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'HSP90 INHIBITORS FOR THERAPEUTIC TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/131303 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14207 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230499.pdf [firstpage_image] =>[orig_patent_app_number] => 13131303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307666 [patent_doc_number] => 20100069486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'ANTI-TUMOR COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/622508 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6124 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069486.pdf [firstpage_image] =>[orig_patent_app_number] => 12622508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231914 [patent_doc_number] => 20100184804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHODS FOR THE PREVENTION OR TREATMENT OF BACTERIAL AND FUNGAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/623307 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 16390 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184804.pdf [firstpage_image] =>[orig_patent_app_number] => 12623307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592537 [patent_doc_number] => 20100130571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/622233 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20586 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130571.pdf [firstpage_image] =>[orig_patent_app_number] => 12622233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875875 [patent_doc_number] => 08470842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor' [patent_app_type] => utility [patent_app_number] => 12/614108 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 12562 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12614108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685290 [patent_doc_number] => 20100120851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 12/614104 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3841 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120851.pdf [firstpage_image] =>[orig_patent_app_number] => 12614104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074386 [patent_doc_number] => 08551963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Imidazolothiazole compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/127978 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35779 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223382 [patent_doc_number] => 20100056617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Role of limonoid compounds as neuroprotective agents' [patent_app_type] => utility [patent_app_number] => 12/590270 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23091 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056617.pdf [firstpage_image] =>[orig_patent_app_number] => 12590270 [rel_patent_id] =>[rel_patent_doc_number] =>)